Ismp promethazine

The Institute for Safe Medication Practices (ISMP) brought attention to the risk of serious tissue damage with parenteral promethazine in August

Nonetheless, the ISMP believes that health care providers, the FDA, and promethazine manufacturers must take further action to prevent these long-standing

In 2024, ISMP recommended removal of injectable promethazine from an organization's formulary, if possible, and use of safer alternatives such as 5-HT 3

and the. ISMP Medication Safety Alert! Community/Ambulatory Care Edition. Events involving these medications were reported to ISMP through either the ISMP

ISMP Safety Alert (2024): Action needed to prevent serious tissue injury with IV promethazine. Accessed J. ISMP : ISMP Targeted Medication Safety Best Practices for Hospitals.

Events involving these medications were reported to ISMP through either the ISMP National Medication Errors Reporting Program (ISMP. MERP) or ISMP National

According to the Institute for Safe Medication Practices (ISMP), promethazine is formulated with phe- nol and has a pH of 4 to 5.5.1 Severe injuries have

and the. ISMP Medication Safety Alert! Community/Ambulatory Care Edition. Events involving these medications were reported to ISMP through either the ISMP

ISMP National Medication Errors Reporting Program (ISMP MERP). In 2024, ISMP recommended removal of injectable promethazine from an